Diabetes adherence - Does gender matter?

Journal of Public Health

Volumn 18, Issue 3, 2010, Pages 219-226

  Geisel Marbaise, Sonja ^a   Stummer, Harald ^a  

^a UMIT Health and Life Sciences University   (Austria)

Author keywords

Adherence; Diabetes; Gender; Pharmacy records

Indexed keywords

ANTIHYPERTENSIVE AGENT; CARDIOVASCULAR AGENT; ORAL ANTIDIABETIC AGENT;

ARTICLE; DIABETES MELLITUS; GERMANY; HEALTH BEHAVIOR; HUMAN; ILLNESS BEHAVIOR; PATIENT COMPLIANCE; SEX DIFFERENCE; TREATMENT REFUSAL;

EID: 77954957541     PISSN: 09431853     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10389-009-0305-2     Document Type: Article

References (51)

1. Aalto A, Uutela A (1997) Glycemic control, self-care behaviors, and psychosocial factors among insulin-treated diabetics: A test of an extended health belief model. Int J Behav Med 4(3):191-214
2. ABDA-Bundesvereinigung Deutsche Apothekerverbände: Non-Compliance kostet 10 Milliarden Euro-Apotheker verbessern Therapietreue. Press release 2007-2106-07 Meran/Berlin
3. ABDA-Bundesvereinigung Deutsche Apothekerverbände: Patienten bevorzugen wohnortnahe Apotheke-Rezeptbelieferung überwiegend am gleichen Tag. Press release 2008-2101-21 Berlin
4. Ahmed AT, Karter AJ, Liu J (2006) Alcohol consumption is inversely associated with adherence to diabetes self-care behaviours. Diabet Med 23:795-802
5. Andrade SE, Kahler KH, Frech F, Chan KA (2006) Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 15(8):565-574
6. Babitsch B (2006) Die Kategorie Geschlecht: Implikationen für den Zusammenhang zwischen sozialer Ungleichheit und Gesundheit. In: Richter M, Hurrelmann K (eds) Gesundheitliche Ungleichheit. Grundlagen, Probleme, Perspektiven, 1st edn. VS Verlag für Sozialwissenschaften, Wiesbaden, pp 271-287
7. Benecke A (2005) Geschlechtsspezifische Aspekte in der Rehabilitation bei Diabetes mellitus. Pabst, Lengerich
8. Claxton AJ, Cramer J, Pierce C (2001) A systematic review of the assocations between dose regimens and medication compliance. Clin Ther 23(8):1296-1310
9. Cosentino M, Leoni O, Banfi F, Lecchini S, Frigo G (2000) An approach for the estimation of drug prescribing using the defined daily dose methodology and drug dispensation data. Eur J Clin Pharmacol 56:513-517
10. Cramer JA (2004) A systematic review of adherence with medications for diabetes. Diabetes Care 27(5):1218-1224
11. Davidson MH (2006) Differences between clinical trial efficacy and real-world effectiveness. Am J Manag Care 12(15):405-411
12. Dezii CM, Kawabata H, Tran M (2002) Effect of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes. South Med J 95(1):68-71
13. Dunn SM, Turtle JR (1981) The myth of the diabetic personality. Diabetes Care 4(6):640-646
14. Fairley CK, Permana A, Read T (2005) Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting. HIV Med 6:366-369
15. Farmer KC (1999) Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practise. Clin Ther 21(6):1074-1090
16. Fincham JE (2007) Patient compliance with medications. Issues and opportunities. Pharmaceutical Products Press, Binghamton New York
17. Fitzgerald JT, Anderson RM, Davis WK (1995) Gender differences in diabetes attitudes and adherence. Diabetes Educ 21:523-529
18. Gerlinger T (2006) Historische Entwicklung und theoretische Perspektiven der Gesundheitssoziologie. In: Wendt C, Wolf C (eds) Soziologie der Gesundheit. VS Verlag für Sozialwissenschaften, Wiesbaden, pp 34-56
19. Guénette L, Moisan J, Préville M, Boyer R (2005) Measures of adherence based self-report exhibited poor agreement with those based on pharmacy records. J Clin Epidemiol 58:924-933
20. Häussler B (2006) Weißbuch diabetes in Deutschland: Bestandsaufnahme und Zukunftsperspektiven der Versorgung einer Volkskrankheit. Thieme, Stuttgart
21. Hearnshaw H, Lindenmeyer A (2005)What do we mean by adherence to treatment and advice for living with diabetes? A review of literature on definitions and measurements. Diabet Med 23:720-728
22. Heuer H, Heuer SH, Lennecke K (1999) Compliance in der Arzneitherapie: Von der Non-Compliance zu pharmazeutischer und medizinischer Kooperation. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart
23. Horne R (1999) Patients' beliefs about treatment: the hidden determinant of treatment outcome? J Psychosom Res 47:491-495
24. Hughes DA, Walley T (2003) Predicting "real world" effectiveness by integrating adherence with pharmacodynamic modeling. Clin Pharmacol Ther 74(1):1-8
25. Icks A (2005) Diabetes mellitus. Gesundheitsberichterstattung des Bundes, 24, Robert Koch-Institute, Berlin
26. Jungbauer-Gans M (2006) Soziale und kulturelle Einflüsse auf Krankheit und Gesundheit. In: Wendt C, Wolf C (eds) Soziologie der Gesundheit. VS Verlag für Sozialwissenschaften, Wiesbaden, pp 86-108
27. Jungbauer-Gans M, Gross C (2006) Gesundheitliche Ungleichheit. Grundlagen, Probleme, Perspektiven. In: Richter M, Hurrelmann K (eds) Gesundheitliche Ungleichheit. Grundlagen, Probleme, Perspektiven, 1st edn. VS Verlag für Sozialwissenschaften,Wiesbaden, pp 73-89
28. Krueger KP, Berger BA, Felkey B (2005) Medication adherence and persistence: A comprehensive review. Adv Ther 22(4):313-356
29. Lai JCL, Cheng S (2004) Health beliefs, optimism, and health-related decisions: A study with Hong Kong Chinese. Int. J Psychol 39 (3):179-189
30. Lange C, Ziese T (2007) Gesundheit in Deutschland. 2. edn. Robert- Koch-Institute (ed) Gesundheitsberichterstattung des Bundes, Berlin
31. Maty SC, Lynch JW, Raghunathan TE, Kaplan GA (2008) Childhood socioeconomic position, gender, adult body mass index, and incidence of type 2 diabetes mellitus over 34 years in the Alameda County Study. Am J Public Health 98(8):1486-1494
32. Max Rubner-Institut, Karlsruhe (ed) (2008) Nationale Verzehrsstudie II, Ergebnisbericht, Teil 1 Die bundesweite Befragung zur Ernährung von Jugendlichen und Erwachsenen
33. Navuluri RB (2000) Gender differences in the factors related to physical activity among adults with diabetes. Nurs Health Sci 2:191-199
34. Renneberg B, Hammelstein P (2006) Gesundheitspsychologie. Heidelberg, Springer Medizin
35. Revicki DA, Frank L (1999) Pharmacoeconomic evaluation in the real world-effectiveness versus efficacy studies. Pharmacoeconomics 15(5):423-434
36. Reymond J, Lennecke K, Marty S (2003) Compliance. In: Jaehde U, Radziwill R, Mühlebach S, Schunack W (eds) Lehrbuch der Klinischen Pharmazie, 2nd edn. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, pp 241-253
37. Rickles NM, Svarstad BL (2007) Relationship between multiple selfreported nonadherence measures and pharmacy records. Res Social Adm Pharm 3(4):363-377
38. Robert-Koch-Institute (ed) (2006) Health in Germany. Federal Health Reporting, Berlin
39. Robiner WN, Yozwiak JA, Bearman DL, Strand TD, Strasburg KR (2009) Barriers to clinical research participation in a diabetes randomized clinical trial. Soc Sci Med 68(6):1069-1074
40. Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R (1999) Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol 52(12):1143-1156
41. Sabaté E (2005) Adherence to long-term therapies: evidence for action. World Health Organization (WHO), Geneva
42. Schoen C, Osborn R, Huynh PT, Doty MM, Fenley JA (November 2005) The Commonwealth Fund 2005 International Health Policy Survey of Sicker Adults in Six Countries. (Commonwealth Fund pub. no. 871) The Commonwealth Fund, New York
43. Schwabe U, Paffrath D (2008) Arzneiverordnungs-Report 2007-Aktuelle Daten, Kosten. Trends und Kommentare, Springer Medizin, Berlin, Heidelberg
44. Schwarzer R (2004) Psychologie des Gesundheitsverhaltens- Einführung in die Gesundheitspsychologie, 3rd edn. Hogrefe, Göttingen
45. Shah NR, Hirsch AG, Zacke C, Taylor S, Wood GC, Stewart WF (2009) Factors associated with first-fill adherence rates for diabetic medications: A cohort study. J Gen Intern Med 24 (2):233-237
46. Steiner JF, Prochazka AV (1997) The assessment of refill compliance using pharmacy records: Methods, validity, and applications. J Clin Epidemiol 50(1):105-116
47. Vedhara K, Wadsworth E, Norman P, Searle A, Mitchell J, Macrae N et al (2004) Habitual prospective memory in elderly patients with type 2 diabetes: implications for medication adherence. Psychol Health Med 9(1):17-27
48. Vermeire E, Hearnshaw H, Van Royen P, Denekens J (2001) Patient adherence to treatment: three decades of research. A comprehensive overview. J Clin Pharm Ther 26(5):331-342
49. Vrijens B, Tousset E, Rode R, Bertz R, Mayer S, Urquhart J (2005) Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosing-time data used as input to individually parameterized pharmacokinetic models. J Clin Pharmacol 45(4):461-467
50. Wolf C, Wendt C (2006) Perspektiven der Gesundheitssoziologie. In: Wendt C, Wolf C (eds) Soziologie der Gesundheit. VS Verlag für Sozialwissenschaften, Wiesbaden, pp 9-33
51. World Health Organization (WHO) (ed) (September 2006) Fact Sheet Diabetes. (Fact Sheet WHO, 312). World Health Organization (WHO), Geneva